Published in Expert Rev Gastroenterol Hepatol on February 01, 2013
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. J Virol (2014) 0.90
Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges. Virulence (2015) 0.82
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments. BMC Med (2015) 0.81
With all the new treatment regimens, complete elimination of hepatitis C virus in Canada is a possibility! But when will Canadians have access these drugs? Can J Gastroenterol Hepatol (2014) 0.75
Status of hepatitis C virus vaccination: Recent update. World J Gastroenterol (2016) 0.75
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A (2006) 3.69
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature (2013) 3.39
A genetically humanized mouse model for hepatitis C virus infection. Nature (2011) 3.15
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68
Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med (2009) 2.26
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (2011) 2.13
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A (2012) 2.05
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut (2014) 1.70
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
A mouse model for HIV-1 entry. Proc Natl Acad Sci U S A (2012) 1.23
Animal models for hepatitis C. Curr Top Microbiol Immunol (2013) 1.17
New horizons for studying human hepatotropic infections. J Clin Invest (2010) 1.16
Rapid development of T cell memory. J Immunol (2004) 1.15
Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med (2013) 1.14
Development of CD1d-restricted NKT cells in the mouse thymus. Eur J Immunol (2004) 1.13
C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. J Virol (2012) 1.05
Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J Immunol (2007) 1.03
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology (2013) 1.01
Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. J Virol (2010) 1.00
H2-M3-restricted memory T cells: persistence and activation without expansion. J Immunol (2003) 0.98
Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice. Immunology (2014) 0.95
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology (2013) 0.93
Barriers of hepatitis C virus interspecies transmission. Virology (2013) 0.92
Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol (2013) 0.91
Development of humanized mouse models to study human malaria parasite infection. Future Microbiol (2012) 0.87
Study of hepatitis C virus entry in genetically humanized mice. Methods (2012) 0.85
Advances and challenges in studying hepatitis C virus in its native environment. Expert Rev Gastroenterol Hepatol (2010) 0.84
Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model. J Virol (2013) 0.84
Modeling malaria in humanized mice: opportunities and challenges. Ann N Y Acad Sci (2015) 0.81
Deconstructing hepatitis C virus infection in humanized mice. Ann N Y Acad Sci (2011) 0.78
Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. J Virol (2013) 0.78
Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines. Hepatology (2012) 0.76
Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice. J Hepatol (2010) 0.75
Teaching new tricks to an old foe: murinizing hepatitis C virus. Hepatology (2010) 0.75